For the live-updated, interactive version of this infographic, click here.
The scattering of points on this chart suggests that Neuropathy is a poorly understood condition.
Why? Well, if it was well understood how to treat Neuropathy, the most effective treatments would also be the most popular, and there would be a nice straight line of points from the top right to the bottom left. Instead, there’s a wide scatter, with some patients finding unpopular solutions that are very effective.
At CureTogether, 803 patients with Neuropathy came together to rate 35 treatments. Here are the current results of this ongoing study.
Patients rate Cymbalta, Neurontin, TENS, and Capsaicin cream as making their Neuropathy worse, not better (see the red part of the chart above.)
The treatments that help most, at the top of the green part of the chart, are: physical therapy, Low-Dose Naltrexone, and water exercise.
While this is just one study, it suggests that more knowledge needs to be gathered on how to best treat Neuropathy, including non-drug treatment options.
The rest of the results are in the graph above, which is divided into four squares…
- Top right: the most popular and effective treatments (including standing up slowly and avoiding smoking)
- Top left: effective treatments that not many people have tried, so they may be options to think about (including LDN and physical therapy)
- Lower right: very popular but not very effective (including Neurontin and vitamin D3)
- Lower left: neither popular nor effective (including Cymbalta and TENS)
Where did this data come from? This is the result of a 3-year CureTogether study on Neuropathy. To thank everyone for participating, we’re publishing this study openly and freely.
This is part of our regular series of research findings. Of course, with each of these findings, there is a potential bias in patient self-selection and recall. Every research study has some bias, so we present these findings as just what they are – patient-reported data – to stimulate discussion and generate new insights for further research.
Please tweet, blog, or pass this along to anyone who can benefit or is interested in Neuropathy. Thank you!